Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia

Antiangiogenic therapy is becoming a promising option for cancer treatment. However, many investigations have recently indicated that these therapies may have limited efficacy, and the cancers in most patients eventually develop resistance to these therapies. There is considerable recently acquired...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yang, Wang, Yu-yi, Wang, Yi-qin, Wang, Xia, Liu, Yan-Yang, Wang, Jian-Tao, Du, Chi, Wang, Li, Li, Mei, Luo, Feng, Jiang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050420/
https://www.ncbi.nlm.nih.gov/pubmed/27703219
http://dx.doi.org/10.1038/srep34239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050420/
https://www.ncbi.nlm.nih.gov/pubmed/27703219
http://dx.doi.org/10.1038/srep34239

Ejemplares similares